Endocrinology
News
DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor use
Until now, SGLT2 inhibitors were for patients with an eGFR of at least 30 mL/min per m2. New evidence moves the threshold down to 25....
News
Obesity boosts risks in COVID-19 from diagnosis to death
Excess pounds are linked to excess infection, hospitalization, ICU admission, and mortality.
News
Gut bacteria linked to cardiovascular, other health conditions
“Microbiota and their metabolites ... could serve as potential therapeutic targets for the maintenance of health and prevention and treatment of...
News
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes
DAPA-CKD showed that dapagliflozin helps patients with albuminuria and declining eGFR levels whether or not they have type 2 diabetes.
News
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effects
HM20 Virtual
Batten down the hatches for thyroid storm
“The big thing is to look for and treat the underlying precipitating event.”
Clinical
Serum cortisol testing for suspected adrenal insufficiency
An isolated serum cortisol is often insufficient to exclude adrenal insufficiency.
News
Evidence mounts for COVID-19 effects on thyroid gland
Among severely ill patients with COVID-19, rates of thyrotoxicosis are significantly higher than among patients without it. But those with thyroid...
News
Does metformin reduce risk for death in COVID-19?
“It is still unclear whether metformin is truly a miracle drug or whether it is simply used more often among people who are healthier and who do...
News
Guidance covers glycemia in dexamethasone-treated COVID-19 patients
The latest document from the COVID-19 response group of the Association of British Clinical Diabetologists is a response to the recent RECOVERY...